The analysts forecast the global short bowel syndrome (SBS) market to grow at a CAGR of 25.53% during the period 2017-2021.

PUNE, INDIA, June 30, 2017 /EINPresswire.com/ --

Global Short Bowel Syndrome (SBS) Market

Description

Short bowel syndrome (SBS) is a metabolic disorder occurs when the portion of the small intestine is not functioning or removed through surgery due to digestive illness. SBS is caused by lack of function of the small intestine. This results in malabsorption, diarrhea, steatorrhea, fluid and electrolyte disturbances, and malnutrition. Based on drug class, the market is segmented into GLP-2, growth hormone, glutamine, and others.

Covered in this report 
The report covers the present scenario and the growth prospects of the global short bowel syndrome (SBS) market for 2017-2021. To calculate the market size, the report considers the sales of the drugs and related nutraceutical products.



Get sample Report @  https://www.wiseguyreports.com/sample-request/1339032-global-short-bowel-syndrome-sbs-market-2017-2021

 

The market is divided into the following segments based on geography: 
• Americas 
• APAC 
• EMEA

The Global Short Bowel Syndrome (SBS) Market 2017-2021, has been prepared based on an in-depth market analysis with inputs from industry experts. The report covers the market landscape and its growth prospects over the coming years. The report also includes a discussion of the key vendors operating in this market.

Key vendors 
• Emmaus Medical 
• Merck 
• Shire

Other prominent vendors 
• Ardelyx 
• Naia Pharmaceuticals 
• Nutrinia 
• OxThera 
• Sancilio Pharmaceuticals 
• Zealand Pharma 
Market driver 
• Special drug designations 
• For a full, detailed list, view our report

Market challenge 
• Severe side effects of the drugs 
• For a full, detailed list, view our report

Market trend 
• Increased awareness of GI disorders 
• For a full, detailed list, view our report

Key questions answered in this report 
• What will the market size be in 2021 and what will the growth rate be? 
• What are the key market trends? 
• What is driving this market? 
• What are the challenges to market growth? 
• Who are the key vendors in this market space? 
• What are the market opportunities and threats faced by the key vendors? 
• What are the strengths and weaknesses of the key vendors?



Complete Report Details @ https://www.wiseguyreports.com/reports/1339032-global-short-bowel-syndrome-sbs-market-2017-2021

 

Table of Contents -Major Key Points

PART 01: Executive summary 

PART 02: Scope of the report 

PART 03: Research Methodology 

PART 04: Introduction 
• Market outline 
• Diagnosis and testing 

PART 05: Orphan drug designation 

PART 06: Pipeline landscape 

PART 07: Market landscape 
• Market overview 
• Five forces analysis 

PART 08: Market segmentation by route of administration (ROA) 
• Oral 
• Parenteral 

PART 09: Market segmentation by drug class 
• GLP-2 
• Growth hormone 
• Glutamine 
• Others 

PART 10: Geographical segmentation 
• SBS market in Americas 
• SBS in EMEA 
• SBS market in APAC 

PART 11: Decision framework 

PART 12: Drivers and challenges 
• Market drivers 
• Market challenges 

PART 13: Market trends 
• Increased awareness of GI disorders 
• Emerging markets 
• Focus on gene therapy 

PART 14: Vendor landscape 
• Competitive scenario 

PART 15: Key vendor analysis 
• Emmaus Medical 
• Merck 
• Shire 
• Other prominent vendors 

………..CONTINUED

 

Buy Now@ https://www.wiseguyreports.com/checkout?currency=one_user-USD&report_id=1339032

 

CONTACT US :

NORAH TRENT

 

Partner Relations & Marketing Manager

sales@wiseguyreports.com

www.wiseguyreports.com

Ph: +1-646-845-9349 (US)

Ph: +44 208 133 9349 (UK)      



About Us

Wise Guy Reports is part of the Wise Guy Consultants Pvt. Ltd. and offers premium progressive statistical surveying, Industryresearch reports, analysis & forecast data for industries and governments around the globe. Wise Guy Reports understand how essential statistical surveying information is for your organization or association. Therefore, we have associated with the top publishers and research firms all specialized in specific domains, ensuring you will receive the most reliable and up to date research data available.

Norah Trent
Wise Guy Consultants Pvt. Ltd.
+1 (339) 368 6938 (US)/+91 841 198 5042 (IND)
email us here